44
Participants
Start Date
May 24, 2018
Primary Completion Date
June 30, 2025
Study Completion Date
November 30, 2025
Nivolumab
Nivolumab is a soluble protein consisting of 4 polypeptide chains, which include 2 identical heavy chains consisting of 440 amino acids and 2 identical light chains. Molecular weight is 146,221 daltons.
Ch14.18/CHO
APN311 (ch14.18/CHO) is manufactured in a Good Manufacturing Practice (GMP) compliant facility of Polymun Scientific, Austria according to a state of the art aseptic manufacturing process based on a characterized and stable Chinese Hamster Ovary (CHO) cell line. After propagation of the working cell bank (WCB) in small volume vessels/bioreactors, manufacture is carried out in a 2500 L stirred tank reactor utilizing components which are free of material of animal or human origin.
University of Wisconsin Carbone Cancer Center; UW Hospital and Clinics; American Family Children's Hospital, Madison
University Hospital Southampton NHS Foundation Trust, Southampton
University College London Hospital, London
University College London Hospitals
OTHER
University of Wisconsin, Madison
OTHER
University Hospital Greifswald
OTHER
Solving Kids' Cancer US/EU
UNKNOWN
Joining Against Cancer in Kids
UNKNOWN
The Band of Parents
UNKNOWN
University Hospital Southampton NHS Foundation Trust
OTHER